Evidence map›Paper›PMID 40622512›Full record

ArticleAIDS and behavior2025

Medical Mistrust and Willingness to Use Long-Acting PrEP Among Black and Hispanic/Latino MSM.

Jerris L Raiford, Robin J MacGowan, Rob Stephenson, Ruth Dana, Lisa Hightow-Weidman, Kristin M Wall, Jeb Jones, Patrick S Sullivan

Abstract read
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerris L RaifordDivision of HIV/AIDS Prevention, HIV Research Branch, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, 1600 Clifton Road NE, Mailstop E-37, Atlanta, GA, 30333, USA. jraiford@cdc.gov.ORCID http://orcid.org/0000-0001-8258-3278
Robin J MacGowanDivision of HIV/AIDS Prevention, HIV Research Branch, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, 1600 Clifton Road NE, Mailstop E-37, Atlanta, GA, 30333, USA.
Rob StephensonSchool of Nursing, University of Michigan, Ann Arbor, USA.
Ruth DanaRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, USA.
Lisa Hightow-WeidmanCollege of Nursing, Institute on Digital Health and Innovation, Florida State University, Tallahassee, USA.
Kristin M WallRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, USA.
Jeb JonesRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, USA.
Patrick S SullivanRollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, USA.

Funding

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention RFA-PS-17-003NCHHSTP CDC HHS U01 PS005181
6 · The paper itself

Abstract

Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV infection in the United States, especially Black MSM (BMSM) and Hispanic/Latino MSM (HLMSM). Long-acting preexposure prophylaxis (LA PrEP) is effective in preventing HIV; however, medical mistrust may contribute to barriers in uptake among BMSM and HLMSM. We assessed the role of medical mistrust in BMSM and HLMSM's unwillingness to use LA PrEP. BMSM and HLMSM aged ≥18 years without a previous HIV diagnosis or current PrEP use were recruited through dating and general interest websites/apps. Using Poisson regression with robust standard errors, we conducted multivariate analyses to assess the association between medical mistrust and willingness to use LA PrEP (i.e., injection or rod implanted in the arm) separately for each racial/ethnic group. Over 90% of the 1,126 BMSM and 924 HLMSM in this study were willing to use some form of PrEP; however, only 74% of BMSM and 81% of HLMSM were willing to use PrEP injections, and significantly fewer BMSM (30%) were willing to receive a PrEP implant compared with 44% of HLMSM. After controlling for sociodemographic, behavioral, and clinical covariates, medical mistrust was associated with lower willingness to use LA PrEP for BMSM, but not for HLMSM. Addressing and reducing medical mistrust among BMSM is important to increase the use of LA PrEP as an effective HIV prevention strategy. Addressing structural barriers and building trust within healthcare systems are crucial steps in reducing disparities in HIV infection among BMSM and HLMSM.

Indexed as

Anti-HIV AgentsBlack or African AmericanHispanic or LatinoHIV InfectionsPatient Acceptance of Health CarePre-Exposure ProphylaxisSexual and Gender MinoritiesAdultEthics, MedicalHealth Knowledge, Attitudes, PracticeHistory, 20th CenturyHomosexuality, MaleHumansMaleMalpracticeMiddle AgedAnti-HIV AgentsBlackHispanic/LatinoLong-actingMedical mistrustMSMPrEPWillingness

Identifiers

PMID40622512
PMCPMC12599396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.